LGALS3 and COVID-19: As COVID-19 transitions from a global health emergency, the evolving epidemiological landscape offers a unique opportunity to refine our understanding and management strategies through innovative molecular research, positioning Gal-3 not only as a diagnostic tool but also as a potential target for therapeutic interventions.